Shares of Ligand Pharmaceuticals Incorporated (LGND) are rallying more than 21 percent Tuesday morning after reporting upbeat fourth-quarter results, above analysts' view.
Net income from continuing operations for the fourth quarter was $18.2 million, or $1.03 per share, compared with a net loss of $14.5 million, or $0.86 per share, for the same period a year ago.
For comments and feedback contact: editorial@rttnews.com
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.